Though pricing continues to be a headwind for cholesterol-reducing drug Repatha, sales still rose 31% in the quarter as need continued to expand at a speedy rate.The pricing model is transparent, with no hidden fees: medication prices $95 month-to-month for the main a few months, which then adjusts to $175 as treatment method progresses to servicin